Simulating ingested micro/nanoplastic transit across the mucus barrier, endocytic capture by enterocytes, and downstream oxidative/inflammatory signaling
Humans ingest an estimated 39,000–52,000 microplastic particles per year from food, water, and airborne fallout settling on meals — a figure that rises several-fold when inhalation is included. Before any biological interaction can be modeled, the particle itself must be characterized: its hydrodynamic diameter, polymer backbone, crystallinity, and surface functionalization together determine whether it is inert cargo passing through the gut or a bioactive nanoparticle capable of crossing the epithelium.
Dietary microplastic exposure arrives through multiple convergent routes:
• Bottled water: up to 325 particles/L (nanoplastic-resolved counts via SRS microscopy, Qian et al. PNAS 2024, mostly <1 µm PET and polyamide from bottle/cap wear) • Seafood and shellfish: bivalves filter-feed and retain MPs in gut tissue consumed whole; mean 0.36–8.6 particles/g wet tissue • Table salt: 0–1674 particles/kg depending on source and refinement • Food packaging migration: PET, PP, and PS fragments shed during heating, scratching, and UV/mechanical weathering • Airborne deposition onto uncovered food and dust ingestion: estimated 60,000–74,000 particles/year via combined routes (Cox et al., Environ. Sci. Technol. 2019)
Polymer identity is confirmed by Fourier-transform infrared (FTIR) or Raman micro-spectroscopy, matching characteristic C-H, C=O, and aromatic ring vibrational bands against reference libraries. The most frequently identified polymers in human stool, placental tissue, and blood are polyethylene (PE), polypropylene (PP), polystyrene (PS), polyethylene terephthalate (PET), and polyvinyl chloride (PVC) — reflecting packaging and textile dominance in global plastic production (~400 Mt/year, of which an estimated 8 Mt enters aquatic systems annually).
Regulatory and toxicological literature partitions plastic debris into macroplastics (>5 mm), microplastics (1 µm–5 mm), and nanoplastics (<1 µm) — the last category behaving less like inert debris and more like engineered nanomaterials in terms of cellular interaction.
Size dictates the physical uptake ceiling: clathrin-coated pits accommodate cargo up to ~200 nm, caveolae up to ~80 nm, while macropinocytosis and phagocytosis (largely restricted to M cells and mucosal dendritic cells) can engulf particles from 0.5 µm up to several microns. Particles above roughly 10 µm are excluded from any active internalization route and pass through the gut as inert bulk cargo.
Surface charge, measured as zeta potential (ζ) by dynamic light scattering electrophoresis, governs the strength of electrostatic interaction with the anionic mucin glycocalyx and the predominantly anionic outer leaflet of the plasma membrane: • Carboxylated/sulfonated particles: ζ ≈ −35 to −45 mV — repelled by mucins but taken up efficiently once past the mucus, via scavenger-receptor-mediated pathways • Aminated (cationic) particles: ζ ≈ +30 to +45 mV — bind mucins and membranes strongly, causing higher local retention and greater membrane-permeabilizing toxicity • Pristine/weathered particles: ζ ≈ −5 to −20 mV, highly variable with UV oxidation state
Within seconds of entering biological fluid, particles adsorb a layer of proteins, lipids, and bile salts — the "eco-corona" or biomolecular corona — that substantially masks the pristine surface chemistry and becomes the effective biological identity the cell actually encounters. Corona composition (albumin, mucin-2, digestive lipases) shifts uptake route and rate by up to 10-fold relative to bare-particle predictions.
Nanoplastics behave less like "small microplastics" and more like a distinct nanomaterial class: below ~200 nm, particles gain access to receptor-mediated endocytosis, paracellular leak pathways, and even direct membrane translocation — routes categorically closed to particles above a few microns. This size-dependent mechanistic switch is why nanoplastic toxicology cannot simply be extrapolated from microplastic feeding studies.
Before any plastic particle reaches the enterocyte surface it must first cross the mucus layer — a dynamically renewed hydrogel of MUC2 mucin glycoproteins that forms the intestine's first physical line of defense. In the colon, mucus organizes into two strata: a loosely attached outer layer colonized by commensal bacteria, and a dense, sterile inner layer (~50 µm) that is essentially impenetrable to bacteria but can still be breached by sufficiently small, appropriately coated synthetic particles.
MUC2, secreted by goblet cells, is a giant (~5 MDa) gel-forming glycoprotein that polymerizes via disulfide-linked trimers into a cross-linked, net-negatively-charged fiber mesh. Its polymer brush structure carries dense O-glycosylation (up to 80% of mass) terminating in sialic acid and sulfate groups, giving the mucus layer an overall anionic character and a mesh pore size in the range of 20–200 nm, modulated by local pH, ionic strength, and mucin concentration gradient.
Particle transit through this mesh follows two rate-limiting regimes:
1. Steric sieving: particles with hydrodynamic diameter approaching or exceeding the local mesh spacing are physically obstructed regardless of surface chemistry. This effectively excludes most microplastics (>1 µm) from ever reaching the epithelium through simple diffusion; their transit instead depends on mucus layer thinning, peristaltic shear, or defects at crypt openings.
2. Adhesive trapping: even nanoscale particles are retarded if they adhere to mucin fibers. Cationic (aminated) nanoplastics interact electrostatically with anionic sialic/sulfate residues and become immobilized — mean squared displacement studies show diffusion coefficients reduced 100–1000-fold relative to bulk water. Densely PEGylated or carboxylated/muco-inert coatings minimize this adhesion, permitting near-unhindered Brownian diffusion ("mucus-penetrating particle" behavior first characterized by Lai, Hanes and colleagues for nanomedicine delivery, applicable in reverse to environmental nanoplastic risk assessment).
Penetration kinetics are typically measured using multiple particle tracking (MPT) on fluorescent polystyrene nanospheres embedded in freshly excised porcine or murine intestinal mucus, or in mucus-secreting Caco-2/HT29-MTX co-culture Transwell models that reconstitute a physiologically relevant mucus layer atop a polarized epithelial monolayer.
Representative findings across the literature: • 100 nm carboxylated PS nanoplastics: effective diffusion coefficient ~0.1–1 µm²/s in native mucus (only 3–10× slower than water) — substantial fractions reach the epithelial surface within the ~1 hour mucus turnover window • 100 nm aminated PS nanoplastics: diffusion coefficient reduced >100-fold; the large majority remain trapped in the outer mucus layer and are cleared with mucus shedding • 500 nm–1 µm particles of any charge: penetration falls sharply, with most flux occurring only at thinned mucus regions overlying Peyer's patch-associated M cells, where the protective mucus layer is naturally attenuated
Mucus thickness and composition are also dynamically perturbed by the plastic exposure itself: several studies report goblet cell hyperplasia and compensatory MUC2 upregulation following chronic microplastic exposure, alongside paradoxical thinning of the protective inner layer under some dietary-emulsifier co-exposure conditions — a barrier-weakening interaction relevant to real-world Western-diet exposure scenarios.
Particles that traverse the mucus and contact the apical brush border of intestinal epithelial cells (enterocytes, and specialized M cells overlying gut-associated lymphoid tissue) encounter a menu of endocytic machinery. Which pathway captures a given particle is governed almost entirely by size and surface chemistry, and the pathway chosen in turn dictates the intracellular fate — recycling back to the lumen, lysosomal degradation, or transcytotic escape into the body.
Clathrin-mediated endocytosis (CME): the dominant route for particles below ~200 nm bearing a defined protein corona that can engage cell-surface receptors (e.g., scavenger receptor SR-A, LRP1). Clathrin triskelia self-assemble into a polyhedral lattice on the cytoplasmic face of the membrane, deforming it into a coated pit that pinches off via the GTPase dynamin within ~1 minute of cargo engagement. Pharmacological inhibition with chlorpromazine or Pitstop-2 reduces nanoplastic uptake by 40–70% in Caco-2 studies, confirming CME as the major quantitative route for sub-200 nm particles.
Caveolin-mediated endocytosis: caveolae are flask-shaped, cholesterol- and sphingolipid-rich membrane invaginations coated by caveolin-1 oligomers, typically 50–80 nm in diameter. This pathway favors particles with negative surface charge and appears preferentially engaged by carboxylated polystyrene and PET nanoplastics; unlike CME, caveolar vesicles are more likely to bypass lysosomal degradation, associated with a distinct trafficking itinerary through caveosomes toward the endoplasmic reticulum and Golgi, raising the possibility of reduced particle breakdown and greater bioavailability.
Macropinocytosis: an actin-driven, receptor-independent process in which membrane ruffles fold back on themselves to engulf large volumes of extracellular fluid and any suspended particulate cargo up to several microns. It is the principal capture route for particles too large for clathrin- or caveolin-coated vesicles and is constitutively upregulated in M cells, which sample luminal antigens (and, incidentally, microplastics) for delivery to underlying Peyer's patch immune cells — making M cell-rich follicle-associated epithelium a disproportionate entry point for larger microplastic fragments relative to their sparse coverage (<10%) of total intestinal surface area.
The Caco-2 human colon adenocarcinoma cell line, grown to confluence on Transwell inserts for 21 days to develop tight junctions and brush-border microvilli, remains the workhorse in vitro model for intestinal microplastic uptake studies, often co-cultured with mucus-producing HT29-MTX cells to approximate a physiological barrier.
Representative quantitative findings (flow cytometry / confocal quantification of fluorescent-labeled polystyrene, PET, and PLA particles): • 50 nm PS nanoplastics: 3–5% of the applied dose internalized within 4 hours of apical exposure • 500 nm PS microplastics: uptake falls to ~0.5–1.5%, dominated by macropinocytosis and M-cell-like sampling • Aminated (+) nanoplastics show 2–3× higher initial membrane adhesion but comparable or lower net internalization versus carboxylated (−) particles, since strong adhesion is often accompanied by membrane-damage-triggered rapid exocytic extrusion (a cellular defense response) • Fasted-state simulated intestinal fluid (containing bile salts and pancreatic lipase) increases apparent nanoplastic uptake 1.5–2× relative to protein-free buffer, consistent with corona-mediated receptor engagement
Enteroid (patient-derived intestinal organoid) models corroborate these trends with more physiologically diverse cell populations (goblet, enteroendocrine, Paneth, and M-like cells), and additionally show that chronic low-dose exposure (7-day repeated dosing) produces cumulative intracellular particle burden without triggering compensatory efflux, suggesting a genuine bioaccumulation risk rather than simple transient pass-through.
Once internalized, microplastic particles are routed through the endolysosomal system — early endosome to late endosome to lysosome — where the acidic, enzyme-rich environment that normally degrades biological cargo instead frequently fails against inert synthetic polymers. This mismatch between lysosomal digestive capacity and polymer chemical inertness is a central driver of particle-induced cellular stress, mirroring mechanisms long described for engineered nanomaterials and crystalline silica.
Following vesicular internalization, cargo-laden endosomes mature through Rab5-positive early endosomes to Rab7-positive late endosomes, ultimately fusing with lysosomes where V-ATPase proton pumps maintain a pH of ~4.5–5.0 and a battery of ~60 acid hydrolases (proteases, lipases, glycosidases) normally degrade engulfed material.
Polystyrene, PET, and polyethylene backbones are chemically resistant to hydrolase attack under physiological conditions — there is no enzymatic machinery in mammalian cells evolved to cleave C-C or aromatic polymer backbones. The result is prolonged (days to weeks) intralysosomal particle residence, analogous to the "frustrated phagocytosis" described for asbestos fibers and some engineered nanomaterials.
Sharper or higher-surface-energy particles, along with those bearing cationic surface coatings, can directly destabilize the lysosomal membrane — a process termed lysosomal membrane permeabilization (LMP). Cathepsin B and other proteases leaking into the cytosol following LMP are a well-established trigger for downstream inflammasome assembly, placing microplastic exposure mechanistically alongside classical particulate danger signals (silica, alum, monosodium urate crystals).
Multiple convergent mechanisms elevate intracellular ROS following microplastic uptake:
• Frustrated phagocytosis and NADPH oxidase (NOX) activation: sustained particle engagement of surface pattern-recognition-adjacent machinery activates NOX enzyme complexes that generate superoxide (O2•−) at the phagosomal membrane • Mitochondrial ROS: particle-induced membrane stress and calcium dysregulation disrupt the electron transport chain, increasing electron leak at Complex I/III and elevating mitochondrial superoxide production; JC-1 and TMRM assays in exposed Caco-2 and HepG2 cells report 20–50% loss of mitochondrial membrane potential at micromolar particle concentrations • Leached additives and adsorbed pollutants: plasticizers (phthalates), UV stabilizers, and hydrophobic organic pollutants (PAHs, PCBs) that partition onto weathered plastic surfaces during environmental transport are co-delivered intracellularly and independently redox-active • Depletion of antioxidant reserves: glutathione (GSH) depletion of 20–40% is commonly reported within 24 hours of exposure in vitro, alongside compensatory upregulation of superoxide dismutase (SOD1/2) and catalase — a signature of an overwhelmed antioxidant response
Dichlorodihydrofluorescein diacetate (DCFH-DA) fluorescence assays across the microplastic toxicology literature consistently report 2–8-fold ROS elevation at concentrations in the 10–100 µg/mL range, with nanoscale and aminated particles producing the largest effect sizes at equivalent mass dose — consistent with their higher uptake efficiency and greater membrane-interaction surface area per unit mass.
The convergence of LMP-released cathepsin B, elevated ROS, and mitochondrial DNA release provides the two-signal requirement for canonical NLRP3 inflammasome activation:
Signal 1 (priming): NF-κB activation (via TLR or cytokine signaling) upregulates transcription of NLRP3 and pro-IL-1β Signal 2 (activation): particulate danger signals (cathepsin B, ROS, K+ efflux from membrane damage) drive NLRP3 oligomerization, recruitment of the adaptor ASC, and caspase-1 activation within the assembled inflammasome complex Caspase-1 then proteolytically matures pro-IL-1β and pro-IL-18 into their active secreted forms, and cleaves gasdermin D to form plasma membrane pores — enabling both cytokine release and, at high activation levels, pyroptotic cell death
In Caco-2/THP-1 co-culture and murine intestinal exposure models, microplastic exposure elevates secreted IL-1β up to 10-fold, alongside increases in IL-6, IL-8, and TNF-α, and measurable tight-junction protein (ZO-1, occludin) redistribution consistent with increased paracellular permeability — a mechanistic link between particulate uptake and the "leaky gut" phenotype reported in several rodent chronic-exposure studies.
The NLRP3 inflammasome pathway activated by microplastics is mechanistically identical to that triggered by asbestos fibers, silica dust, and gout-associated urate crystals — a shared "particulate danger signal" axis. This positions chronic low-dose microplastic exposure within a well-characterized toxicological framework for particle-driven sterile inflammation, rather than requiring an entirely novel mechanism of harm.
A subset of internalized particles escape the enterocyte apical compartment entirely, undergoing transcytosis across the basolateral membrane into the lamina propria — the final and most consequential step converting a gut-lumen exposure into a systemic burden. From there, particles enter either the portal venous circulation en route to the liver or the intestinal lymphatics, with downstream distribution now directly documented in human tissue.
Transcytosis — vesicular transport of intact cargo across a polarized epithelial cell from apical to basolateral surface without lysosomal degradation — is the decisive step for systemic translocation. Caveolin-associated vesicles are disproportionately implicated, since their trafficking itinerary more readily bypasses the degradative lysosomal pathway compared to clathrin-derived vesicles, which are more often routed to late endosomes/lysosomes for destruction or apical recycling.
Once particles reach the lamina propria beneath the epithelium, two anatomical routes diverge:
• Portal venous route: particles entering submucosal blood capillaries drain via the portal vein directly to the liver, the first-pass filtration organ for essentially all absorbed gut content — consistent with the liver being among the most consistently positive organs for microplastic detection in autopsy and biopsy tissue studies • Lymphatic route: larger particles (typically >100 nm, and especially those absorbed via M-cell/Peyer's patch macropinocytosis) preferentially enter lacteals and mesenteric lymphatics, bypassing first-pass hepatic filtration and draining via the thoracic duct directly into systemic venous circulation — a route well-precedented for lipid nanoparticle and chylomicron transport and increasingly implicated for larger microplastic fragments
M cells specifically appear to provide a disproportionate translocation route: despite covering under 10% of intestinal surface area, follicle-associated epithelium accounts for a substantially larger fraction of measured particle flux in ligated intestinal loop and organoid co-culture studies, reflecting both thinner overlying mucus and constitutively active macropinocytic/phagocytic sampling.
Direct human tissue evidence for microplastic translocation has accumulated rapidly since 2020, using pyrolysis-GC/MS for bulk polymer mass quantification and Raman/FTIR micro-spectroscopy for particle-resolved identification:
• Placenta (Ragusa et al., Environment International 2021): PP and other polymer particles identified on both maternal and fetal sides of term placentas, demonstrating that nanoscale particles can cross the placental barrier • Liver and kidney (multiple 2022–2024 studies): PE, PVC, and PET consistently detected in human liver and kidney tissue at concentrations in the low µg/g range, with liver cirrhosis patients showing significantly elevated burden versus healthy controls in some cohorts • Carotid artery plaque (Marfella et al., New England Journal of Medicine 2024): patients with PE/PVC detected in excised carotid atheroma had a 4.5-fold higher risk of myocardial infarction, stroke, or death over 34-month follow-up versus plaque without detectable plastic — the first prospective clinical outcome data linking tissue microplastic burden to cardiovascular events • Human brain tissue (Nihart et al., Nature Medicine 2024): decedent brain samples contained substantially higher plastic mass concentration than liver or kidney from the same individuals, with polyethylene the dominant polymer and nanoscale particle morphology observed by electron microscopy, raising the possibility of blood-brain barrier crossing by the smallest size fractions • Human blood (Leslie et al., Environment International 2022): quantifiable plastic polymer detected in ~80% of donor blood samples tested (mean 1.6 µg/mL), establishing that translocated particles do reach systemic circulation at detectable concentrations in the general population
Mechanistically, nanoscale (sub-200 nm) particles are considered most capable of crossing specialized barriers such as the blood-brain barrier and placental barrier, via transcytosis routes analogous to those described in the gut epithelium, while microscale particles accumulate predominantly in reticuloendothelial organs (liver, spleen) that filter particulate matter from blood.
The 2024 NEJM carotid plaque study by Marfella and colleagues is the first to connect measured tissue microplastic/nanoplastic burden to a hard clinical cardiovascular endpoint in a prospective cohort — moving the field from cell-culture and rodent mechanistic data toward direct human outcome evidence, and substantially raising the regulatory and public-health stakes of chronic dietary microplastic exposure.